- Home
- SNAL vs ICAD Comparison
SNAL vs ICAD Comparison
Compare SNAL & ICAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNAL
- ICAD
- Stock Information
- Founded
- SNAL 2000
- ICAD 1984
- Country
- SNAL United States
- ICAD United States
- Employees
- SNAL N/A
- ICAD N/A
- Industry
- SNAL Computer Software: Prepackaged Software
- ICAD Medical/Dental Instruments
- Sector
- SNAL Technology
- ICAD Health Care
- Exchange
- SNAL Nasdaq
- ICAD Nasdaq
- Market Cap
- SNAL 92.8M
- ICAD 87.5M
- IPO Year
- SNAL 2022
- ICAD 1986
- Fundamental
- Price
- SNAL $2.09
- ICAD $2.70
- Analyst Decision
- SNAL
- ICAD
- Analyst Count
- SNAL 0
- ICAD 0
- Target Price
- SNAL N/A
- ICAD N/A
- AVG Volume (30 Days)
- SNAL 104.1K
- ICAD 821.7K
- Earning Date
- SNAL 03-31-2025
- ICAD 03-11-2025
- Dividend Yield
- SNAL N/A
- ICAD N/A
- EPS Growth
- SNAL N/A
- ICAD N/A
- EPS
- SNAL 0.08
- ICAD N/A
- Revenue
- SNAL $86,822,973.00
- ICAD $18,940,000.00
- Revenue This Year
- SNAL $39.43
- ICAD $12.07
- Revenue Next Year
- SNAL $26.12
- ICAD $3.44
- P/E Ratio
- SNAL $27.65
- ICAD N/A
- Revenue Growth
- SNAL 82.23
- ICAD 10.03
- 52 Week Low
- SNAL $0.52
- ICAD $1.18
- 52 Week High
- SNAL $3.42
- ICAD $3.78
- Technical
- Relative Strength Index (RSI)
- SNAL 45.01
- ICAD 45.47
- Support Level
- SNAL $2.15
- ICAD $3.20
- Resistance Level
- SNAL $3.42
- ICAD $3.75
- Average True Range (ATR)
- SNAL 0.31
- ICAD 0.35
- MACD
- SNAL -0.08
- ICAD -0.12
- Stochastic Oscillator
- SNAL 9.52
- ICAD 6.14
About SNAL Snail Inc.
Snail Inc is a global independent developer and publisher of interactive digital entertainment for consumers around the world, with a premier portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States.
About ICAD iCAD Inc.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.